Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1

Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1 Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2 Design and synthesis of novel CCR3 antagonists Synthesis and structure–activity relationship of benzetimide derivatives as human CXCR3 antagonists Discovery of 4-[4-({(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl}methyl)phenoxy]benzoic acid hydrochloride: A highly potent orally available CCR5 selective antagonist Synthesis and Structure−Activity Relationships of 8-(Pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: Potent, Orally Bioavailable Corticotropin Releasing Factor Receptor-1 (CRF₁) Antagonists Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton Cyclohexylmethylpiperidinyltriphenylpropioamide:  A Selective Muscarinic M₃ Antagonist Discriminating against the Other Receptor Subtypes Discovery of a novel, potent and selective human β3-adrenergic receptor agonist Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β₃-Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I